<DOC>
	<DOCNO>NCT02124759</DOCNO>
	<brief_summary>The purpose study determine effect high fat consumption intestinal microbiome , metabolic endotoxemia , insulin action , lean normal glucose tolerant subject .</brief_summary>
	<brief_title>Mechanism Microbiome-induced Insulin Resistance Humans ( Aim 1 )</brief_title>
	<detailed_description>We test hypothesis high fat diet give lean , normal glucose tolerant subject modify gut microbiome composition enhance intestinal permeability , increase plasma LPS concentration , induce inflammatory response peripheral tissue ( skeletal muscle ) , impair insulin signal sensitivity . Also test hypothesis inflammatory response insulin resistance cause high fat ingestion ameliorate administer - synbiotic ( Bifidobacterium longum R0175 oligofructose ) protect intestinal epithelial barrier decrease intestinal translocation LPS ; - sevelamer , agent sequesters lipopolysaccharide ( LPS ) gastrointestinal tract limit translocation circulation .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Sevelamer</mesh_term>
	<criteria>Both gender . All race ethnic group . Premenopausal woman follicular phase , nonlactating , negative pregnancy test . Postmenopausal woman stable dose expose hormone replacement ≥6 month . Hematocrit ( HCT ) ≥ 34 % , serum creatinine ≤ 1.4 mg/dl , normal serum electrolyte , urinalysis , coagulation test . Liver function test ( LFTs ) 2 time normal . Stable body weight ( ±2 % ) ≥ 3 month Two less session strenuous exercise/wk last 6 month . Presence diabetes impaired glucose tolerance base ADA criterion . Current treatment drug know affect glucose lipid homeostasis . If subject stable dose past 3 month , follow agent permit : calcium channel blocker , βblockers , ACE inhibitor , angiotensin receptor blocker , statins History allergy sevelamer . History Nonsteroidal antiinflammatory drug systemic steroid use week within 3 month . Current treatment anticoagulant ( warfarin ) . Aspirin ( 325 mg ) clopidogrel permit hold seven day prior biopsy accordance primary physician . Use agent affect gut flora ( e.g . antibiotic , colestyramine , lactulose , PEG ) within 3 month . History heart disease ( New York Heart Classification great grade II ; nonspecific STT wave change ECG ) , peripheral vascular disease , pulmonary disease , smoker . Poorly control blood pressure ( systolic BP &gt; 170 , diastolic BP &gt; 95 mmHg ) . Active inflammatory , autoimmune , hepatic , gastrointestinal , malignant , psychiatric disease . History gastrointestinal surgery gastrointestinal obstruction within two year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>